KeyBanc raised the firm’s price target on Emerson (EMR) to $150 from $125 and keeps an Overweight rating on the shares following an eventful Q1 earnings season and the firm’s recent Industrials and Basic Materials Conference in Boston. While broader macro uncertainty remains elevated amid highly fluid global trade dynamics, KeyBanc thinks recent data points relative to its coverage have been better than feared.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: